Mike Mensinger - 02 Dec 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)

Role
Chief Product Officer
Signature
/s/ Stephen Feider, Attorney-in-Fact
Issuer symbol
BBNX
Transactions as of
02 Dec 2025
Net transactions value
-$31,184
Form type
4
Filing time
04 Dec 2025, 16:20:10 UTC
Previous filing
04 Sep 2025
Next filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mensinger Mike Chief Product Officer C/O BETA BIONICS, INC., 11 HUGHES, IRVINE /s/ Stephen Feider, Attorney-in-Fact 04 Dec 2025 0002048500

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBNX Common Stock Sale $31,184 -1,063 -1.2% $29.34 90,752 02 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.